Tonix Pharmaceuticals Holding Corp.TNXPNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+14.9%
5Y CAGR+26.2%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+14.9%/yr
vs +36.3%/yr prior
5Y CAGR
+26.2%/yr
Recent deceleration
Acceleration
-21.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.2x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$45.78M+14.2%
2024$40.10M+15.4%
2023$34.75M+15.0%
2022$30.21M+28.7%
2021$23.47M+63.8%
2020$14.33M+34.7%
2019$10.64M+21.4%
2018$8.76M+10.3%
2017$7.95M-23.8%
2016$10.44M-